Literature DB >> 30145800

Upregulated microRNA-485 suppresses apoptosis of renal tubular epithelial cells in mice with lupus nephritis via regulating the TGF-β-MAPK signaling pathway by inhibiting RhoA expression.

Yu Tian1, Yu-Xiang Han1, Hui-Fang Guo1, Hong-Tao Jin1, Chao Sun1, Xuan Qi1, Li-Yan Ma1, Shi-Wei Bo2.   

Abstract

Lupus nephritis (LN) is a common and severe complication of systemic lupus erythematosus. Without intervention, LN may cause acute kidney injury and end-stage renal disease. This study aims to determine whether microRNA-485 (miR-485) affects renal tubular epithelial cells (RTECs) in LN mice via the TGF-β-MAPK signaling pathway by targeting RhoA. Renal tissue samples were initially extracted from 15 LN and 15 normal mice. RTECs were cultivated in vitro and grouped after transfection of different mimics, inhibitors, or siRNA- RhoA. The target gene of miR-485 was confirmed by dual-luciferase reporter assay. Flow cytometry and MTT assay were applied to detect cell viability and apoptosis. It was determined that RhoA was a target gene of miR-485. We found that urine protein, creatinine, RhoA, interleukin 6 (IL-6), transforming growth factor-β1 (TGF-β1), and p38 mitogen-activated protein kinases (p38MAPK) were highly expressed in renal tissues of LN mice, while poor levels of miR-485 were recorded. The overexpression of miR-485 or siRNA- RhoA or the combination of miR-485 and siRNA- RhoA was demonstrated to lead to a reduction of levels of RhoA, IL-6, TGF-β, and p38MAPK, as well as a promotion of RTECs proliferation and inhibition of RTECs apoptosis. Taken together, these findings indicated that overexpressed miR-485 downregulates RhoA which could promote cell viability and inhibit apoptosis of RTECs by regulating the RhoA-mediated TGF-β-MAPK signaling pathway in LN mice.
© 2018 Wiley Periodicals, Inc.

Entities:  

Keywords:  RhoA gene; TGF-β-MAPK signaling pathway; cell apoptosis; cell viability; lupus nephritis; microRNA-485; renal tubular epithelial cell

Mesh:

Substances:

Year:  2018        PMID: 30145800     DOI: 10.1002/jcb.27178

Source DB:  PubMed          Journal:  J Cell Biochem        ISSN: 0730-2312            Impact factor:   4.429


  6 in total

1.  Sphingosine kinase 1 inhibition decreases the epithelial-mesenchymal transition and ameliorates renal fibrosis via modulating NF-κB signaling.

Authors:  Fei He; Maoxiao Fan; Yansheng Jin; Haiyan Wang; Lan Ding; Jianfeng Fan; Shuaishuai Gu; Wen Xu
Journal:  Am J Transl Res       Date:  2019-09-15       Impact factor: 4.060

2.  Splicing factor SRSF1 limits IFN-γ production via RhoH and ameliorates experimental nephritis.

Authors:  Takayuki Katsuyama; Hao Li; Suzanne M Krishfield; Vasileios C Kyttaris; Vaishali R Moulton
Journal:  Rheumatology (Oxford)       Date:  2021-01-05       Impact factor: 7.580

3.  FKN Facilitates HK-2 Cell EMT and Tubulointerstitial Lesions via the Wnt/β-Catenin Pathway in a Murine Model of Lupus Nephritis.

Authors:  Dongdong Fu; Soulixay Senouthai; Junjie Wang; Yanwu You
Journal:  Front Immunol       Date:  2019-04-30       Impact factor: 7.561

4.  MicroRNA-140-5p ameliorates the high glucose-induced apoptosis and inflammation through suppressing TLR4/NF-κB signaling pathway in human renal tubular epithelial cells.

Authors:  Jie Su; Jian Ren; Haiyan Chen; Bo Liu
Journal:  Biosci Rep       Date:  2020-03-27       Impact factor: 3.840

5.  Glycol chitosan-based tacrolimus-loaded nanomicelle therapy ameliorates lupus nephritis.

Authors:  Chang Seong Kim; Ansuja Pulickal Mathew; Arathy Vasukutty; Saji Uthaman; Soo Yeon Joo; Eun Hui Bae; Seong Kwon Ma; In-Kyu Park; Soo Wan Kim
Journal:  J Nanobiotechnology       Date:  2021-04-17       Impact factor: 10.435

6.  Fasudil prevents liver fibrosis via activating natural killer cells and suppressing hepatic stellate cells.

Authors:  Qiu-Ju Han; Yong-Liang Mu; Hua-Jun Zhao; Rong-Rong Zhao; Quan-Juan Guo; Yu-Hang Su; Jian Zhang
Journal:  World J Gastroenterol       Date:  2021-06-28       Impact factor: 5.742

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.